|
1
|
Yap FHX, Amanuel B, Van Vliet C, Thomas M
and Wong D: Malignant transformation of fibrous dysplasia into
osteosarcoma confirmed with TP53 somatic mutation and mutational
analysis of GNAS gene. Pathology. 53:652–654. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geary RL, Corrigan LR, Carney DN and
Higgins MJ: Osteosarcoma and second malignant neoplasms: A case
series. Ir J Med Sci. 188:1163–1167. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu ZJ, Tan JC, Qin X, Liu B and Yuan ZC:
Significance of circulating tumor cells in osteosarcoma patients
treated by neoadjuvant chemotherapy and surgery. Cancer Manag Res.
10:3333–3339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hız M, Karaismailoglu B, Ulutas S,
Camurdan VB, Gorgun B and Oner Dincbas F: The effect of
preoperative radiotherapy on local control and prognosis in
high-grade non-metastatic intramedullary osteosarcoma of the
extremities. Arch Orthop Trauma Surg. 141:1083–1089. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang B and Zhang Y, Li R, Li J, Lu X and
Zhang Y: The efficacy and safety comparison of first-line
chemotherapeutic agents (high-dose methotrexate, doxorubicin,
cisplatin, and ifosfamide) for osteosarcoma: A network
meta-analysis. J Orthop Surg Res. 15:512020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rainusso N, Wang LL and Yustein JT: The
adolescent and young adult with cancer: State of the art - bone
tumors. Curr Oncol Rep. 15:296–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liao YX, Yu HY, Lv JY, Cai YR, Liu F, He
ZM and He SS: Targeting autophagy is a promising therapeutic
strategy to overcome chemoresistance and reduce metastasis in
osteosarcoma. Int J Oncol. 55:1213–1222. 2019.PubMed/NCBI
|
|
8
|
Zhou B, Li L, Qiu X, Wu J, Xu L and Shao
W: Long non-coding RNA ANRIL knockdown suppresses apoptosis and
pro-inflammatory cytokines while enhancing neurite outgrowth via
binding microRNA-125a in a cellular model of Alzheimer's disease.
Mol Med Rep. 22:1489–1497. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Long X, Li L, Zhou Q, Wang H, Zou D, Wang
D, Lou M and Nian W: Long non-coding RNA LSINCT5 promotes ovarian
cancer cell proliferation, migration and invasion by disrupting the
CXCL12/CXCR4 signalling axis. Oncol Lett. 15:7200–7206.
2018.PubMed/NCBI
|
|
10
|
Song B, Ye L, Wu S and Jing Z: Long
non-coding RNA MEG3 regulates CSE-induced apoptosis and
inflammation via regulating miR-218 in 16HBE cells. Biochem Biophys
Res Commun. 521:368–374. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang PS, Wang Z and Yang C: Dysregulations
of long non-coding RNAs - The emerging ‘lnc’ in environmental
carcinogenesis. Semin Cancer Biol. Apr 3–2021.(Epub ahead of
print). doi: 10.1016/j.semcancer.2021.03.029. View Article : Google Scholar
|
|
12
|
Bhan A, Soleimani M and Mandal SS: Long
Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rajagopal T, Talluri S, Akshaya RL and
Dunna NR: HOTAIR lncRNA: A novel oncogenic propellant in human
cancer. Clin Chim Acta. 503:1–18. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rui X, Xu Y, Jiang X, Ye W, Huang Y and
Jiang J: Long non-coding RNA C5orf66-AS1 promotes cell
proliferation in cervical cancer by targeting miR-637/RING1 axis.
Cell Death Dis. 9:11752018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu T, Liu H and You G: Long non-coding RNA
C5orf66-AS1 prevents oral squamous cell carcinoma through
inhibiting cell growth and metastasis. Int J Mol Med. 42:3291–3299.
2018.PubMed/NCBI
|
|
16
|
Tang XJ, Wang W and Hann SS: Interactions
among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie.
163:58–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Shen S, Li Z, Li W and Weng X:
MIR-140-5p affects chondrocyte proliferation, apoptosis, and
inflammation by targeting HMGB1 in osteoarthritis. Inflamm Res.
69:63–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu WX, Liu Z, Deng F, Wang DD, Li XW, Tian
T, Zhang J and Tang JH: miR-145: A potential biomarker of cancer
migration and invasion. Am J Transl Res. 11:6739–6753.
2019.PubMed/NCBI
|
|
19
|
Gulino R, Forte S, Parenti R, Memeo L and
Gulisano M: MicroRNA and pediatric tumors: Future perspectives.
Acta Histochem. 117:339–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Llobat L and Gourbault O: Role of
microRNAs in human osteosarcoma: Future perspectives. Biomedicines.
9:4632021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Liu S, Shi J, Li J, Wang S, Liu H,
Zhao S, Duan K, Pan X and Yi Z: The Role of miRNA in the Diagnosis,
Prognosis, and Treatment of Osteosarcoma. Cancer Biother
Radiopharm. 34:605–613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo K, He J, Yu D and Açil Y: miR-149-5p
regulates cisplatin chemosensitivity, cell growth, and metastasis
of oral squamous cell carcinoma cells by targeting TGFβ2. Int J
Clin Exp Pathol. 12:3728–3739. 2019.PubMed/NCBI
|
|
23
|
Ye X and Chen X: miR-149-5p inhibits cell
proliferation and invasion through targeting GIT1 in medullary
thyroid carcinoma. Oncol Lett. 17:372–378. 2019.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang C, Ma K and Li WY: IL-6 promotes
cancer stemness and oncogenicity in U2OS and MG-63 osteosarcoma
cells by upregulating the OPN-STAT3 pathway. J Cancer.
10:6511–6525. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ozturk S, Gorgun C, Gokalp S, Vatansever S
and Sendemir A: Development and characterization of cancer stem
cell-based tumoroids as an osteosarcoma model. Biotechnol Bioeng.
117:2527–2539. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anderson PM: Radiopharmaceuticals for
treatment of osteosarcoma. Adv Exp Med Biol. 1257:45–53. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heng M, Gupta A, Chung PW, Healey JH,
Vaynrub M, Rose PS, Houdek MT, Lin PP, Bishop AJ, Hornicek FJ, et
al Japanese Musculoskeletal Oncology Group (JMOG); Soft Tissue
Osteosarcoma International Collaborative (STOIC), : The role of
chemotherapy and radiotherapy in localized extraskeletal
osteosarcoma. Eur J Cancer. 125:130–141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang YF, Lu L, Shen HL and Lu XX: lncRNA
SNHG4 promotes osteosarcoma proliferation and migration by sponging
miR-377-3p. Mol Genet Genomic Med. 8:e13492020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Fei M, Zhou X, Li Y and Jin D: The
potential value of lncRNA-BC050642 in osteosarcoma origination and
outcomes. Artif Cells Nanomed Biotechnol. 47:1859–1866. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Q, Li H, Jing J, Yuan Y and Sun L:
Evaluation of C5orf66-AS1 as a potential biomarker for predicting
early gastric cancer and its role in gastric carcinogenesis.
OncoTargets Ther. 13:2795–2805. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu G, Li C, Xie W, Wang Z, Gao H, Cao L,
Hao L and Zhang Y: Long non-coding RNA C5orf66-AS1 is downregulated
in pituitary null cell adenomas and is associated with their
invasiveness. Oncol Rep. 38:1140–1148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Y, Yin L, Li H, Liu LH and Xiao T:
The lncRNA LINC00963 facilitates osteosarcoma proliferation and
invasion by suppressing miR-204-3p/FN1 axis. Cancer Biol Ther.
20:1141–1148. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiaobo Z, Qizhi H, Zhiping W and Tao D:
Down-regulated miR-149-5p contributes to preeclampsia via
modulating endoglin expression. Pregnancy Hypertens. 15:201–208.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu M, Xiao J, Chen M, Yuan L, Li J, Shen H
and Yao S: miR-149-5p promotes chemotherapeutic resistance in
ovarian cancer via the inactivation of the Hippo signaling pathway.
Int J Oncol. 52:815–827. 2018.PubMed/NCBI
|
|
36
|
Jiang J, Xie C, Liu Y, Shi Q and Chen Y:
Up-regulation of miR-383-5p suppresses proliferation and enhances
chemosensitivity in ovarian cancer cells by targeting TRIM27.
Biomed Pharmacother. 109:595–601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marín-Béjar O, Mas AM, González J,
Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E,
Guo S, Rouzaut A, Ulitsky I and Huarte M: The human lncRNA
LINC-PINT inhibits tumor cell invasion through a highly conserved
sequence element. Genome Biol. 18:1–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: lncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Russo A, Cardile V, Graziano ACE, Avola R,
Bruno M and Rigano D: Involvement of Bax and Bcl-2 in induction of
apoptosis by essential oils of three lebanese salvia species in
human prostate cancer cells. Int J Mol Sci. 19:E2922018. View Article : Google Scholar
|
|
40
|
Zhang W, Li JZ, Tai QY, Tang JJ, Huang YH
and Gao SB: lncRNA DANCR regulates osteosarcoma migration and
invasion by targeting miR-149/MSI2 axis. Eur Rev Med Pharmacol Sci.
24:6551–6560. 2020.PubMed/NCBI
|
|
41
|
Chao Y, Hu K, Wang X and Wang L:
MicroRNA-552 promotes migration and invasion of osteosarcoma
through targeting TIMP2. Biochem Biophys Res Commun. 511:63–68.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen T, Chen Z, Lian X, Wu W, Chu L, Zhang
S and Wang L: MUC 15 Promotes osteosarcoma cell proliferation,
migration and invasion through Livin, MMP-2/MMP-9 and Wnt/β-catenin
signal pathway. J Cancer. 12:467–473. 2021. View Article : Google Scholar : PubMed/NCBI
|
